Pfizer-BioNTech make another application to provide existing vaccine to adolescents

Coronavirus vaccines being prepared at Salisbury Cathedral Wiltshire as the rollout continues

The European Commission has launched legal proceedings against the Anglo-Swedish drugmaker, alleging that it did not respect its contract or have a "reliable" plan to ensure timely deliveries of coronavirus shots.

BioNTech and Pfizer had previously requested their emergency use authorisation with the US Food and Drug Administration to be extended to children aged 12-15.

Sahin said that current trials for younger age groups were "very encouraging" with figures suggesting "children are very well protected by the vaccine".

More than 1 cr doses already with local govts, says Centre; delivery in next 3 daysNEWDELHI Nearly 16.16 crore vaccine doses have been provided to the states and the Union Territories free of cost while additional 20 lakh doses will reach them in next three days, the Union Ministry of Health and Family Welfare said in a statement on Thursday.

The White House said earlier this week that the US would begin sharing its entire stock of AstraZeneca vaccine with the world once it clears federal safety reviews, with as many as 60 million doses expected to be available for export in the coming months. In case if anyone misses the scheduled time of their second dose, they will receive an SMS with a rescheduled appointment at a PHCC health center.

When AstraZeneca released data from its US vaccine trial on March 22, company officials said they expected to apply for FDA authorization in the first half of April.

"When we looked at the early was a moment of joy, and the re-analysis of a greater number of patients is very reassuring, it does show the biology of the vaccine working in this high-risk group".

The EU's roll out still lags behind other advanced economies, such as the United Kingdom and the USA, after a botched start mired by procurement, authorization and delivery delays.

Despite accelerated deliveries and distribution, public health officials say it's "too early to celebrate" and vaccines will do little to help provinces now struggling to stem infections during a tough third wave of the pandemic.

So far, 300 million doses of the shot had been made available in 165 countries, the drugmaker said. AstraZeneca in turn authorizes other companies to produce the shots around the world.



Other news